Metabolic Effects Beyond Weight Loss Both medication types improve metabolic markers, but dual agonists might offer some advantages in certain areas
This classification applies whether you receive medications from a traditional pharmacy or a licensed compounding pharmacy
It also heightens the risk of several cancers, including colorectal, post-menopausal breast, uterine, esophageal, kidney and pancreatic cancers (WHO 2024
The study, published Monday in the journal Nature Medicine, is one of the first big-picture looks at the benefits and risks of these new drugs, which rapidly made an impact on health care, insurance coverage, the grocery industry, and even the economy of an entire country (Denmark, where Novo Nordisk, the maker of Ozempic and Wegovy is based.) These drugs have also been given partial credit for a recent dip in obesity rates in the US, which dropped in 2023 for the first time in over a decade
Better Long-Term Health In the long term, adopting a healthy diet can improve the effectiveness of GLP-1 agonists, enhancing blood sugar control, reducing the risk of heart disease and kidney failure, and promoting overall health
